MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

HQY

76.28

-4.98%↓

PDCO

31.05

+0.49%↑

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

HQY

76.28

-4.98%↓

PDCO

31.05

+0.49%↑

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

HQY

76.28

-4.98%↓

PDCO

31.05

+0.49%↑

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

HQY

76.28

-4.98%↓

PDCO

31.05

+0.49%↑

MDT

81.74

-1.59%↓

VEEV

209.29

-2.32%↓

A

98.9

-4.01%↓

HQY

76.28

-4.98%↓

PDCO

31.05

+0.49%↑

Search

Dynavax Technologies Corp

Chiusa

SettoreSettore sanitario

11.71 -6.17

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

11.62

Massimo

12.76

Metriche Chiave

By Trading Economics

Entrata

-11M

7.1M

Vendite

-8.6M

72M

P/E

Media del settore

63.55

63.778

EPS

0.05

Margine di Profitto

9.787

Dipendenti

405

EBITDA

2.2M

12M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+102.16% upside

Dividendi

By Dow Jones

Utili prossimi

7 mag 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-139M

1.6B

Apertura precedente

17.88

Chiusura precedente

11.71

Notizie sul Sentiment di mercato

By Acuity

51%

49%

312 / 386 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Very Strong Bearish Evidence

Dynavax Technologies Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

7 apr 2025, 23:56 UTC

Notizie principali

Australian Consumer Confidence Firms Despite Market Falls

7 apr 2025, 23:45 UTC

Azioni calde

Stocks to Watch: CVS Health, UnitedHealth Group, Spire Global, Pacira BioSciences

7 apr 2025, 21:36 UTC

I principali Market Mover

Medicare Insurer Shares Rise on Plans for Higher Payment Rates

7 apr 2025, 21:11 UTC

I principali Market Mover

Broadcom Authorizes $10 Billion Share Repurchase Program

7 apr 2025, 23:48 UTC

Discorsi di Mercato

Nikkei May Rise After Recent Selloffs -- Market Talk

7 apr 2025, 23:47 UTC

Discorsi di Mercato

Gold Edges Lower Amid More Cautious Near-Term Outlook -- Market Talk

7 apr 2025, 23:34 UTC

Notizie principali

Apple Users Rush to Upgrade iPhones Ahead of Potential Tariffs-Related Price Hikes -- WSJ

7 apr 2025, 22:18 UTC

Notizie principali

Health Insurer Stocks Jump After Medicare Boosts Payment Rates -- Barrons.com

7 apr 2025, 22:04 UTC

Notizie principali

Trump Turns Screws on China, Leaves Door Open to Deals With Other Countries -- WSJ

7 apr 2025, 21:43 UTC

Discorsi di Mercato

Oil Producers Choosing Returns Over Growth In Tariffs Fallout -- Market Talk

7 apr 2025, 21:37 UTC

Discorsi di Mercato

Canada Faces Financial Crisis-Like Symptoms That Rate Cuts Won't Cure -- Market Talk

7 apr 2025, 21:32 UTC

Acquisizioni, Fusioni, Takeovers

Infineon: All-Cash Transaction to Be Financed From Existing Liquidity and Additional Debt >IFX.FF

7 apr 2025, 21:32 UTC

Acquisizioni, Fusioni, Takeovers

Infineon: Transaction Combines Infineon's Portfolio for Automotive Microcontrollers With Automotive Ethernet Business of Marvell, Accelerating Infineon's System Capabilities for Software-Defined Vehicles >IFX.FF

7 apr 2025, 21:32 UTC

Acquisizioni, Fusioni, Takeovers

Infineon: Business Expected to Generate Rev of $225M-$250M in Calendar Yr 2025 With Gross Margin of Around 60% >IFX.FF

7 apr 2025, 21:32 UTC

Acquisizioni, Fusioni, Takeovers

Infineon: Enters Agreement for Acquisition of Marvell Technology's Automotive Ethernet Business for US$2.5 B >IFX.FF

7 apr 2025, 21:31 UTC

Notizie principali

Apple Plans to Source More iPhones From India as Potential Tariff Fix -- Update

7 apr 2025, 21:29 UTC

Notizie principali

PNC Names Former BlackRock Star Mark Wiedman as President -- WSJ

7 apr 2025, 21:28 UTC

Acquisizioni, Fusioni, Takeovers

Infineon Further Strengthens Its Number One Position In Automotive Microcontrollers And Boosts Systems Capabilities For Software-defined Vehicles With Acquisition Of Marvell's Automotive Ethernet Business >IFNNY MRVL

7 apr 2025, 21:21 UTC

Notizie principali

Defense Stocks Can't Escape the Trade War. Expect to Hear This Term. -- Barrons.com

7 apr 2025, 21:18 UTC

Notizie principali
Utili

Levi Strauss Trying to Mitigate Tariff Impact on Consumer; Company Grows Revenue -- Update

7 apr 2025, 21:17 UTC

Utili

Levi Sees U.S. Consumer 'Generally Resilient,' CFO Says

7 apr 2025, 21:17 UTC

Utili

Levi Looking at Cost-Related Opportunities, Pricing Changes as Part of Response, CFO Says

7 apr 2025, 21:16 UTC

Utili

Levi Strauss Sets Up Task Force to Understand Implications of Trump's Tariffs, CFO Singh Says

7 apr 2025, 21:16 UTC

Notizie principali

What to Know About Trump's Latest Tariffs -- 3rd Update

7 apr 2025, 21:15 UTC

Acquisizioni, Fusioni, Takeovers

Marvell to Sell In-Vehicle Network Portfolio for $2.5B

7 apr 2025, 21:14 UTC

Notizie principali

PNC Taps Ex-BlackRock Star Mark Wiedman as President -- WSJ

7 apr 2025, 21:06 UTC

Notizie principali
Acquisizioni, Fusioni, Takeovers

Trump Orders New Review of Nippon-U.S. Steel Merger -- 3rd Update

7 apr 2025, 21:03 UTC

Notizie principali

Even Google Could Feel the Sting of a Trade War -- Barrons.com

7 apr 2025, 20:59 UTC

Notizie principali

U.S. Stock Meltdown Gives Way to Global Rout -- WSJ

7 apr 2025, 20:56 UTC

I principali Market Mover

Broadcom Authorizes $10B Share Repurchase Program

Confronto tra pari

Modifica del prezzo

Dynavax Technologies Corp Previsione

Obiettivo di Prezzo

By TipRanks

102.16% in crescita

Previsioni per 12 mesi

Media 25.25 USD  102.16%

Alto 33 USD

Basso 12 USD

Basato su 5 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Dynavax Technologies Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

5 ratings

4

Acquista

0

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

12.49 / 12.85Supporto e resistenza

A breve termine

Very Strong Bearish Evidence

A termine intermedio

Very Strong Bearish Evidence

A lungo termine

Weak Bullish Evidence

Sentiment

By Acuity

312 / 386 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove ribassiste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Dynavax Technologies Corp

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.